Growth Equity

Despite a 19% revenue jump amidst Greece's record tourism year, hotel group The Azur Selection posts a €5.7M loss, triggering a 'going concern' warning.

A new startup unveils an AI server with 128TB of memory, promising to slash costs, lower energy use, and unlock AI models previously thought impossible.

AI Council 2026 reveals the industry's next chapter: European founders are flocking to SF, engineering is being reinvented, and video is set to break everything.

A new AI video solution from V4b.AI promises to solve generative AI's accuracy problem, offering brands a scalable, shoot-free alternative for content.

The firm's oversubscribed fund highlights investor confidence in its strategy of backing founder-owned industrial and services companies.

A Calgary startup's revolutionary wound care gel, already used in hospitals, is now being funded by the government for battlefield trauma applications.

Following a major investment from Gryphon Investors, HRSoft is stacking its board with tech veterans to accelerate growth, product innovation, and M&A.

With a new CEO from finance and media, and $10M in fresh capital, The Block is betting big on becoming the go-to data source for Wall Street's crypto move.

RedHill Biopharma flips a capital deficit to positive equity, driven by savvy partnerships for its drugs Talicia and Bekinda and a promising R&D pipeline.

While many ed-tech firms scale back, 2U secures new capital, betting its future on closing the multi-trillion-dollar AI skills gap with elite partners.

Porsche sells its stake in Bugatti Rimac to focus on its core business, paving the way for Rimac Group and new investors to accelerate a new hypercar future.

With a major investment from FTV Capital, fintech firm Valitana is set to accelerate its AI-driven transformation of the complex structured credit world.

The fast-growing pizza franchise accelerates its national push into Kansas and Tennessee, leveraging a low-cost model and new tech to challenge industry giants.

Backed by strategic capital, a new venture led by healthcare veterans aims to close care gaps for Florida's families with a tech-driven, value-based model.

For the 5th straight year, WA's life sciences outpace job growth. See how AI leadership and strategic investment fuel its $43.4B economic impact.

Natus Sensory is bringing back the trusted Otometrics name to unify its hearing and balance portfolio, a strategic move with deep market implications.

With a seasoned dealmaker at the helm, Elkedonia is advancing a first-in-class, non-hallucinogenic drug for depression targeting a novel protein.

The Chinese pharma giant's Q1 results reveal a successful pivot to innovation, with blockbuster deals and a strategic Nasdaq listing paving its global path.

Kensington Capital's sixth SPAC begins trading its warrants separately, signaling the next phase in its search for a high-growth automotive or AI company.

Harrington Discovery Institute opens its 2027 award call, offering millions in funding and expert support to turn academic research into life-saving medicines.